← Leaderboards
Patrick Duffy
National Institute Of Allergy And Infectious Diseases
$0
Attributed
$0
Total exposure
0
Grants
0
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding mix
By agency
—
By mechanism
—
Top collaborators
No co-investigators on record.
Most similar at National Institute Of Allergy And Infectious Diseases
Same institution · by research overlap
Others in their field
Top investigators on “Malaria”
- Lawrence Corey · Fred Hutchinson Cancer Center$227,738,417
- Glenda E Gray · Wits Health Consortium (Pty), Ltd$227,738,417
- Margaret Juliana McElrath · Fred Hutchinson Cancer Center$82,291,297
- Stephen Lev Hoffman · Sanaria, Inc.$79,440,588
- Constance Ann Benson · University Of California, San Diego$65,790,143
- David Heimbrook · Leidos Biomedical Research, Inc.$61,561,099
Research focus
MalariaParasitesVaccinesMalaria VaccinesPlasmodium FalciparumTransmission ProcessAreaProteinsAntigensVaccine CandidateInfectionMaliAntibodiesCulicidaeImmunogenicityMalaria TransmissionReportingBaseRecombinantsImmunityAnimalsSurfaceResponseImmune Response
Grant awards (177)
Vaccines to Interrupt Malaria Transmission: Clinical Development$8,068,044
ZIA · FY2025 · AI · contact PI
Malaria Pathogenesis in young children and vaccine discovery$2,069,553
ZIA · FY2025 · AI · contact PI
Vaccines to Interrupt Malaria Transmission: Discovery and Assays$1,892,505
ZIA · FY2025 · AI · contact PI
Pregnancy Malaria Vaccine development$967,251
ZIA · FY2025 · AI · contact PI
Pre-erythrocytic malaria vaccines: Discovery and Clinical Development$967,251
ZIA · FY2025 · AI · contact PI
T Cell Regulatory and Suppression Mechanisms in Malaria$84,110
ZIA · FY2025 · AI · contact PI
COVID-19 Serosurveys and Vaccine Study Site Preparations$84,110
ZIA · FY2025 · AI · contact PI
Malaria Vaccines: Pfs25-rEPA and Pfs230-rEPA$6,889,173
ZIA · FY2024 · AI · contact PI
Optimizing malaria transmission-blocking vaccines with improved platforms$2,649,684
ZIA · FY2024 · AI · contact PI
Assays to Support Development of Malaria Transmission Blocking Vaccines$1,706,624
ZIA · FY2024 · AI · contact PI
Malaria Transmission Blocking Vaccine Discovery$1,059,874
ZIA · FY2024 · AI · contact PI
Malaria Pathogenesis in young children and vaccine discovery$800,611
ZIA · FY2024 · AI · contact PI
Pregnancy Malaria Vaccine development$757,335
ZIA · FY2024 · AI · contact PI
Evaluation of Novel Preerythrocytic Anti-infection Malaria Vaccine Candidates$238,020
ZIA · FY2024 · AI · contact PI
Assessment of malaria whole organism vaccines$216,382
ZIA · FY2024 · AI · contact PI
Malaria Vaccines: Pvs230D1-EPA and PvCSP$86,556
ZIA · FY2024 · AI · contact PI
T Cell Regulatory and Suppression Mechanisms in Malaria$21,640
ZIA · FY2024 · AI · contact PI
Malaria Surveillance and Research Studies in Liberia and Guinea-Conakry$21,640
ZIA · FY2024 · AI · contact PI
COVID-19 Serosurveys and Vaccine Study Site Preparations$13,666
ZIA · FY2024 · AI · contact PI
Malaria Vaccines: Pfs25-rEPA and Pfs230-rEPA$7,594,868
ZIA · FY2023 · AI · contact PI
Optimizing malaria transmission-blocking vaccines with improved platforms$2,921,105
ZIA · FY2023 · AI · contact PI
Assays to Support Development of Malaria Transmission Blocking Vaccines$2,728,182
ZIA · FY2023 · AI · contact PI
Malaria Transmission Blocking Vaccine Discovery$1,168,442
ZIA · FY2023 · AI · contact PI
Malaria Pathogenesis in young children and vaccine discovery$672,945
ZIA · FY2023 · AI · contact PI
COVID-19 Serosurveys and Vaccine Study Site Preparations$603,919
ZIA · FY2023 · AI · contact PI
Pregnancy Malaria Vaccine development$582,007
ZIA · FY2023 · AI · contact PI
Evaluation of Novel Preerythrocytic Anti-infection Malaria Vaccine Candidates$236,441
ZIA · FY2023 · AI · contact PI
Assessment of malaria whole organism vaccines$218,253
ZIA · FY2023 · AI · contact PI
Malaria Vaccines: Pvs230D1-EPA and PvCSP$72,752
ZIA · FY2023 · AI · contact PI
Malaria Surveillance and Research Studies in Liberia and Guinea-Conakry$18,188
ZIA · FY2023 · AI · contact PI
T Cell Regulatory and Suppression Mechanisms in Malaria$18,188
ZIA · FY2023 · AI · contact PI
Malaria Vaccines: Pfs25-rEPA and Pfs230-rEPA$6,665,131
ZIA · FY2022 · AI · contact PI
Optimizing malaria transmission-blocking vaccines with improved platforms$2,563,513
ZIA · FY2022 · AI · contact PI
Assays to Support Development of Malaria Transmission Blocking Vaccines$2,328,632
ZIA · FY2022 · AI · contact PI
Malaria Transmission Blocking Vaccine Discovery$1,025,407
ZIA · FY2022 · AI · contact PI
Malaria Pathogenesis in young children and vaccine discovery$495,693
ZIA · FY2022 · AI · contact PI
Pregnancy Malaria Vaccine development$464,712
ZIA · FY2022 · AI · contact PI
COVID-19 Serosurveys and Vaccine Study Site Preparations$390,420
ZIA · FY2022 · AI · contact PI
Assessment of malaria whole organism vaccines$325,299
ZIA · FY2022 · AI · contact PI
Evaluation of Novel Preerythrocytic Anti-infection Malaria Vaccine Candidates$170,396
ZIA · FY2022 · AI · contact PI
Malaria Vaccines: Pvs230D1-EPA and PvCSP$61,964
ZIA · FY2022 · AI · contact PI
Malaria Surveillance and Research Studies in Liberia and Guinea-Conakry$15,493
ZIA · FY2022 · AI · contact PI
T Cell Regulatory and Suppression Mechanisms in Malaria$15,492
ZIA · FY2022 · AI · contact PI
Malaria Vaccines: Pfs25-rEPA and Pfs230-rEPA$6,432,150
ZIA · FY2021 · AI · contact PI
Assays to Support Development of Malaria Transmission Blocking Vaccines$3,226,715
ZIA · FY2021 · AI · contact PI
Optimizing malaria transmission-blocking vaccines with improved platforms$2,473,905
ZIA · FY2021 · AI · contact PI
Malaria Transmission Blocking Vaccine Discovery$989,562
ZIA · FY2021 · AI · contact PI
COVID-19 Serosurveys and Vaccine Study Site Preparations$780,824
ZIA · FY2021 · AI · contact PI
Malaria Pathogenesis in young children and vaccine discovery$542,662
ZIA · FY2021 · AI · contact PI
Pregnancy Malaria Vaccine development$542,662
ZIA · FY2021 · AI · contact PI
Assessment of malaria whole organism vaccines$367,610
ZIA · FY2021 · AI · contact PI
Evaluation of Novel Preerythrocytic Anti-infection Malaria Vaccine Candidates$192,557
ZIA · FY2021 · AI · contact PI
Malaria Vaccines: Pvs230D1-EPA and PvCSP$70,022
ZIA · FY2021 · AI · contact PI
Malaria Surveillance and Research Studies in Liberia and Guinea-Conakry$17,507
ZIA · FY2021 · AI · contact PI
T Cell Regulatory and Suppression Mechanisms in Malaria$17,507
ZIA · FY2021 · AI · contact PI
Malaria Vaccines: Pfs25-rEPA and Pfs230-rEPA$6,509,799
ZIA · FY2020 · AI · contact PI
Assays to Support Development of Malaria Transmission Blocking Vaccines$3,087,956
ZIA · FY2020 · AI · contact PI
Malaria Vaccines: TBV Antigens as Conjugates with Alternate Carriers$3,037,907
ZIA · FY2020 · AI · contact PI
Malaria Transmission Blocking Vaccine Discovery$1,301,961
ZIA · FY2020 · AI · contact PI
COVID-19 Serosurveys and Vaccine Study Site Preparations$576,660
ZIA · FY2020 · AI · contact PI
Malaria Pathogenesis in young children and vaccine discovery$545,207
ZIA · FY2020 · AI · contact PI
Assessment of malaria whole organism vaccines$436,165
ZIA · FY2020 · AI · contact PI
Pregnancy Malaria Vaccine development$372,153
ZIA · FY2020 · AI · contact PI
Evaluation of Novel Preerythrocytic Anti-infection Malaria Vaccine Candidates$245,344
ZIA · FY2020 · AI · contact PI
Vaccine Optimization Program$138,356
ZIA · FY2020 · AI · contact PI
Malaria Vaccines: Pvs230D1-EPA and PvCSP$81,782
ZIA · FY2020 · AI · contact PI
T Cell Regulatory and Suppression Mechanisms in Malaria$40,891
ZIA · FY2020 · AI · contact PI
Malaria Surveillance and Research Studies in Liberia and Guinea-Conakry$13,631
ZIA · FY2020 · AI · contact PI
Malaria Vaccines: Pfs25-rEPA and Pfs230-rEPA$6,535,818
ZIA · FY2019 · AI · contact PI
Assays to Support Development of Malaria Transmission Blocking Vaccines$3,995,345
ZIA · FY2019 · AI · contact PI
Malaria Vaccines: TBV Antigens as Conjugates with Alternate Carriers$3,050,048
ZIA · FY2019 · AI · contact PI
Malaria Transmission Blocking Vaccine Discovery$1,307,165
ZIA · FY2019 · AI · contact PI
Malaria Immunology and Pathogenesis in Pregnant Women and Young Children$566,204
ZIA · FY2019 · AI · contact PI
Assessment of malaria whole organism vaccines$410,498
ZIA · FY2019 · AI · contact PI
Pregnancy Malaria Vaccine development$329,462
ZIA · FY2019 · AI · contact PI
Evaluation of Novel Preerythrocytic Anti-infection Malaria Vaccine Candidates$226,483
ZIA · FY2019 · AI · contact PI
Vaccine Optimization Program$184,456
ZIA · FY2019 · AI · contact PI
T Cell Regulatory and Suppression Mechanisms in Malaria$141,552
ZIA · FY2019 · AI · contact PI
Malaria Vaccines: Pvs230D1-EPA and PvCSP$56,622
ZIA · FY2019 · AI · contact PI
Malaria Surveillance and Research Studies in Liberia and Guinea-Conakry$14,157
ZIA · FY2019 · AI · contact PI
Assays to Support Development of Malaria Transmission Blocking Vaccines$5,422,499
ZIA · FY2018 · AI · contact PI
Malaria Vaccines: Pfs25-rEPA and Pfs230-rEPA$5,020,301
ZIA · FY2018 · AI · contact PI
Malaria Transmission Blocking Vaccine Discovery$4,289,527
ZIA · FY2018 · AI · contact PI
Malaria Vaccines: TBV Antigens as Conjugates with Alternate Carriers$2,510,151
ZIA · FY2018 · AI · contact PI
Malaria Immunology and Pathogenesis in Pregnant Women and Young Children$916,342
ZIA · FY2018 · AI · contact PI
Assessment of malaria whole organism vaccines$664,348
ZIA · FY2018 · AI · contact PI
Evaluation of Novel Preerythrocytic Anti-infection Malaria Vaccine Candidates$366,537
ZIA · FY2018 · AI · contact PI
Pregnancy Malaria Vaccine development$301,331
ZIA · FY2018 · AI · contact PI
T Cell Regulatory and Suppression Mechanisms in Malaria$229,085
ZIA · FY2018 · AI · contact PI
Vaccine Optimization Program$185,151
ZIA · FY2018 · AI · contact PI
Malaria Vaccines: Pvs230D1-EPA and PvCSP$91,634
ZIA · FY2018 · AI · contact PI
Malaria Surveillance and Research Studies in Liberia$22,909
ZIA · FY2018 · AI · contact PI
Malaria Transmission Blocking Vaccine Discovery$8,566,689
ZIA · FY2017 · AI · contact PI
Malaria Vaccines: Pfs25-rEPA and Pfs230-rEPA$5,397,843
ZIA · FY2017 · AI · contact PI
Assays to Support Development of Malaria Transmission Blocking Vaccines$3,401,099
ZIA · FY2017 · AI · contact PI
Malaria Vaccines: TBV Antigens as Conjugates with Alternate Carriers$2,076,094
ZIA · FY2017 · AI · contact PI
Malaria Immunology and Pathogenesis in Pregnant Women and Young Children$742,469
ZIA · FY2017 · AI · contact PI
Assessment of malaria whole organism vaccines$556,851
ZIA · FY2017 · AI · contact PI
Pregnancy Malaria Vaccine development$303,879
ZIA · FY2017 · AI · contact PI
Evaluation of Novel PE Malaria Vaccine Candidates$296,987
ZIA · FY2017 · AI · contact PI
T Cell Regulatory and Suppression Mechanisms in Malaria$185,617
ZIA · FY2017 · AI · contact PI
Malaria Vaccines: Pvs230D1-EPA and PvCSP$74,247
ZIA · FY2017 · AI · contact PI
Malaria Vaccines: Pfs25-rEPA and Pfs230-rEPA$7,278,594
ZIA · FY2016 · AI · contact PI
Assays to Support Development of Malaria Transmission Blocking Vaccines$3,484,751
ZIA · FY2016 · AI · contact PI
Malaria Transmission Blocking Vaccine Discovery$1,261,623
ZIA · FY2016 · AI · contact PI
Malaria Vaccines: TBV Antigens as Conjugates with Alternate Carriers$1,164,575
ZIA · FY2016 · AI · contact PI
Assessment of malaria whole organism vaccines$758,747
ZIA · FY2016 · AI · contact PI
Malaria Immunology and Pathogenesis in Pregnant Women and Young Children$505,831
ZIA · FY2016 · AI · contact PI
T Cell Regulatory and Suppression Mechanisms in Malaria$252,916
ZIA · FY2016 · AI · contact PI
Evaluation of Novel PE Malaria Vaccine Candidates$168,610
ZIA · FY2016 · AI · contact PI
Assays to Support Development of Malaria Transmission Blocking Vaccines$4,089,130
ZIA · FY2015 · AI · contact PI
Malaria Vaccine: Pfs25-rEPA$3,665,425
ZIA · FY2015 · AI · contact PI
Malaria Vaccine: Pfs230-rEPA$3,665,425
ZIA · FY2015 · AI · contact PI
Malaria Transmission Blocking Vaccine Discovery$1,320,426
ZIA · FY2015 · AI · contact PI
Assessment of whole organism vaccinations in Malian Adults$451,901
ZIA · FY2015 · AI · contact PI
Malaria Immunology and Pathogenesis in Pregnant Women and Young Children$451,901
ZIA · FY2015 · AI · contact PI
Malaria Vaccine: Pfs25/Pfs230-OMPC/MERCK ALUMINUM ADJUVANT$440,142
ZIA · FY2015 · AI · contact PI
Pregnancy Malaria: Pathogenesis and Immunity$361,521
ZIA · FY2015 · AI · contact PI
T Cell Regulatory and Suppression Mechanisms in Malaria$271,141
ZIA · FY2015 · AI · contact PI
Evaluation of Novel PE Malaria Vaccine Candidates$271,141
ZIA · FY2015 · AI · contact PI
Mali International Center for Excellence in Research: Malaria Clinical Research$3,736,920
ZIA · FY2014 · AI · contact PI
Malaria Vaccine: Pfs25-rEPA$2,356,798
ZIA · FY2014 · AI · contact PI
Malaria Vaccine: Pfs230$2,356,798
ZIA · FY2014 · AI · contact PI
Gametocyte Carriage Rate and Transmission Blocking Vaccine Assay Development$1,571,199
ZIA · FY2014 · AI · contact PI
Malaria Vaccine: Pfs25-Pvs25$1,178,399
ZIA · FY2014 · AI · contact PI
Malaria Immunology and Pathogenesis in Pregnant Women and Young Children$970,501
ZIA · FY2014 · AI · contact PI
Pregnancy Malaria: Pathogenesis and Immunity$582,301
ZIA · FY2014 · AI · contact PI
Malaria Vaccine: Pfs25-OMPC/MERCK ALUMINUM ADJUVANT$392,800
ZIA · FY2014 · AI · contact PI
Evaluation of Novel PE Malaria Vaccine Candidates$388,200
ZIA · FY2014 · AI · contact PI
Assessment of whole organism vaccinations in Malian Adults$164,850
ZIA · FY2014 · AI · contact PI
The Role of T Cell Regulatory Mechanisms in Protection from Severe Malaria$18,317
ZIA · FY2014 · AI · contact PI
Malaria Vaccine: Pfs25-rEPA$3,362,281
ZIA · FY2013 · AI · contact PI
Mali International Center for Excellence in Research: Malaria Clinical Research$2,130,518
ZIA · FY2013 · AI · contact PI
Malaria Vaccine: Pfs230$1,681,141
ZIA · FY2013 · AI · contact PI
Gametocyte Carriage Rate and Transmission Blocking Vaccine Assay Development$1,176,799
ZIA · FY2013 · AI · contact PI
Evaluation of Novel PE Malaria Vaccine Candidates$1,175,442
ZIA · FY2013 · AI · contact PI
Malaria Vaccine: Pfs25-Pvs25$672,456
ZIA · FY2013 · AI · contact PI
Malaria Vaccine: Pfs25-OMPC/MERCK ALUMINUM ADJUVANT$672,456
ZIA · FY2013 · AI · contact PI
Pregnancy Malaria: Pathogenesis and Immunity$489,767
ZIA · FY2013 · AI · contact PI
Malaria Vaccine: CSP-rEPA$420,285
ZIA · FY2013 · AI · contact PI
Malaria Vaccine: Pfs28/Pvs28$420,285
ZIA · FY2013 · AI · contact PI
Malaria Immunology and Pathogenesis in Pregnant Women and Young Children$293,860
ZIA · FY2013 · AI · contact PI
Malaria Vaccine: Pfs25-rEPA$4,033,409
ZIA · FY2012 · AI · contact PI
Mali International Center for Excellence in Research: Malaria Clinical Research$1,486,314
ZIA · FY2012 · AI · contact PI
Malaria Vaccine: Pfs25-OMPC/MERCK ALUMINUM ADJUVANT$806,682
ZIA · FY2012 · AI · contact PI
Malaria Vaccine: CSP-rEPA$806,682
ZIA · FY2012 · AI · contact PI
Malaria Immunology and Pathogenesis in Pregnant Women and Young Children$780,091
ZIA · FY2012 · AI · contact PI
Pregnancy Malaria: Pathogenesis and Immunity$682,580
ZIA · FY2012 · AI · contact PI
Evaluation of Novel PE Malaria Vaccine Candidates$487,557
ZIA · FY2012 · AI · contact PI
Gametocyte Carriage Rate and Transmission Blocking Vaccine Assay Development$403,341
ZIA · FY2012 · AI · contact PI
Malaria Vaccine: Pfs28/Pvs28$403,341
ZIA · FY2012 · AI · contact PI
Malaria Vaccine: Pfs230$403,341
ZIA · FY2012 · AI · contact PI
Malaria Vaccine: Pfs25-Pvs25$403,341
ZIA · FY2012 · AI · contact PI
Malaria Vaccine: BSAM$403,341
ZIA · FY2012 · AI · contact PI
Malaria Vaccine: AMA1-C1$403,341
ZIA · FY2012 · AI · contact PI
Malaria Vaccine: Pfs25-rEPA$2,085,065
ZIA · FY2011 · AI · contact PI
Malaria Vaccine: CSP-rEPA$1,672,898
ZIA · FY2011 · AI · contact PI
Malaria Vaccine: BSAM$1,260,732
ZIA · FY2011 · AI · contact PI
Malaria Vaccine: AMA1-C1$1,260,732
ZIA · FY2011 · AI · contact PI
Malaria Vaccine: Pfs230$848,566
ZIA · FY2011 · AI · contact PI
Evaluation of Novel PE Malaria Vaccine Candidates$691,420
ZIA · FY2011 · AI · contact PI
Malaria Immunology and Pathogenesis in Pregnant Women and Young Children$691,420
ZIA · FY2011 · AI · contact PI
Malaria Vaccine: Pfs28/Pvs28$436,399
ZIA · FY2011 · AI · contact PI
Malaria Vaccine: Pfs25-Pvs25$353,966
ZIA · FY2011 · AI · contact PI
Malaria Vaccine: AMA1-C1/ISA 720$353,966
ZIA · FY2011 · AI · contact PI
Malaria Vaccine: Pfs25-OMPC/MERCK ALUMINUM ADJUVANT$189,099
ZIA · FY2011 · AI · contact PI
Malaria Vaccine: Pfs25-rEPA$2,036,508
ZIA · FY2010 · AI · contact PI
Malaria Vaccine: CSP-rEPA$1,629,207
ZIA · FY2010 · AI · contact PI
Malaria Vaccine: BSAM$1,527,381
ZIA · FY2010 · AI · contact PI
Malaria Vaccine: AMA1-C1$1,323,730
ZIA · FY2010 · AI · contact PI
Malaria Vaccine: Pfs25-Pvs25$1,323,730
ZIA · FY2010 · AI · contact PI
Malaria Vaccine: AMA1-C1/ISA 720$610,952
ZIA · FY2010 · AI · contact PI
Malaria Vaccine: Pfs230$610,952
ZIA · FY2010 · AI · contact PI
Malaria Vaccine: Pfs28/Pvs28$509,127
ZIA · FY2010 · AI · contact PI
Evaluation of Novel PE Malaria Vaccine Candidates with Recombinant Adenoviruses$323,529
ZIA · FY2010 · AI · contact PI
Malaria Immunology and Pathogenesis in Pregnant Women and Young Children$298,642
ZIA · FY2010 · AI · contact PI
Malaria Vaccine: Pfs25-OMPC/MERCK ALUMINUM ADJUVANT$101,825
ZIA · FY2010 · AI · contact PI